Chinese hamster ovary cell

Results: 85



#Item
1B’SYS GmbH CHO GlyRα3 Cell Line Specification Sheet © B’SYS GmbH

B’SYS GmbH CHO GlyRα3 Cell Line Specification Sheet © B’SYS GmbH

Add to Reading List

Source URL: www.bsys.ch

Language: English - Date: 2016-05-11 07:41:45
2B’SYS GmbH CHO KV4.3 / KChiP2 Cell Line Specification Sheet © B’SYS GmbH

B’SYS GmbH CHO KV4.3 / KChiP2 Cell Line Specification Sheet © B’SYS GmbH

Add to Reading List

Source URL: www.bsys.ch

Language: English - Date: 2016-05-11 07:43:52
3B’SYS GmbH CHO ASIC1b Cell Line Specification Sheet © B’SYS GmbH

B’SYS GmbH CHO ASIC1b Cell Line Specification Sheet © B’SYS GmbH

Add to Reading List

Source URL: www.bsys.ch

Language: English - Date: 2016-05-12 05:26:02
4Delivering ‘fit for purpose’ biomanufacturing CHO cell lines Authors: Leon P. Pybus*, Nazanin Dadehbeigi*, Fay L. Saunders, Alison J. Porter

Delivering ‘fit for purpose’ biomanufacturing CHO cell lines Authors: Leon P. Pybus*, Nazanin Dadehbeigi*, Fay L. Saunders, Alison J. Porter

Add to Reading List

Source URL: www.fujifilmdiosynth.com

Language: English - Date: 2015-06-20 23:54:12
5TNKase® (Tenecteplase) DESCRIPTION TNKase® (Tenecteplase) is a tissue plasminogen activator (tPA) produced by recombinant DNA technology using an established mammalian cell line (Chinese Hamster Ovary cells). Tenectepl

TNKase® (Tenecteplase) DESCRIPTION TNKase® (Tenecteplase) is a tissue plasminogen activator (tPA) produced by recombinant DNA technology using an established mammalian cell line (Chinese Hamster Ovary cells). Tenectepl

Add to Reading List

Source URL: www.gene.com

Language: English - Date: 2015-04-20 16:45:05
    6CMC Biologics Licenses its CHEF1® Expression System to Oxford BioTherapeutics Seattle, WA USA/Copenhagen, Denmark and Oxford, UK – September 7, 2011 – CMC Biologics and Oxford BioTherapeutics (OBT) today announced t

    CMC Biologics Licenses its CHEF1® Expression System to Oxford BioTherapeutics Seattle, WA USA/Copenhagen, Denmark and Oxford, UK – September 7, 2011 – CMC Biologics and Oxford BioTherapeutics (OBT) today announced t

    Add to Reading List

    Source URL: www.cmcbio.com

    Language: English - Date: 2014-06-06 18:31:30
    7THE JOURNAL OF BIOLOGICAL CHEMISTRY © 1997 by The American Society for Biochemistry and Molecular Biology, Inc. Vol. 272, No. 25, Issue of June 20, pp –15840, 1997 Printed in U.S.A.

    THE JOURNAL OF BIOLOGICAL CHEMISTRY © 1997 by The American Society for Biochemistry and Molecular Biology, Inc. Vol. 272, No. 25, Issue of June 20, pp –15840, 1997 Printed in U.S.A.

    Add to Reading List

    Source URL: cms.unige.ch

    Language: English - Date: 2010-06-02 11:59:09
    8DrugPlus international - November 2004 • 0 A novel technology for the production of highly active therapeutic proteins by Dr. Hans Baumeister and Dr. Steffen Goletz

    DrugPlus international - November 2004 • 0 A novel technology for the production of highly active therapeutic proteins by Dr. Hans Baumeister and Dr. Steffen Goletz

    Add to Reading List

    Source URL: www.glycotope.com

    Language: English - Date: 2012-06-20 10:10:40
    9Contact: Meg Duskin Marketing Communications Managerworkcell)

    Contact: Meg Duskin Marketing Communications Managerworkcell)

    Add to Reading List

    Source URL: www.maxcyte.com

    Language: English - Date: 2015-05-06 15:19:14
    10Mammalian Cell Culture Development Using Phenotype Microarrays Jiuyi 1 Lu ,

    Mammalian Cell Culture Development Using Phenotype Microarrays Jiuyi 1 Lu ,

    Add to Reading List

    Source URL: biolog.com

    Language: English - Date: 2013-07-26 13:46:10